Bioactive compounds containing thiadiazole

Current Bioactive Compounds

Volumn 6, Issue 4, 2010, Pages 243-265

  Pierro, Paola ^a   Bellone, Gabriella ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Biologically active compounds; Heterocycles; Thiadiazole

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THIADIAZOLE DERIVATIVE;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; DRUG MECHANISM; DRUG STRUCTURE; DYSLIPIDEMIA; ESCHERICHIA COLI; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1; NEUROPROTECTION; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

EID: 78649995408     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340710793237326     Document Type: Article

References (51)

1. Kornis, G. In: Comprehensive Heterocyclic Chemistry I. Katritzky, A. R.; Rees, C. W. Eds., Pergamon, Oxford, 1984; Vol. 6, pp. 546-547.
2. Kornis, G. In: Comprehensive Heterocyclic Chemistry I. Katritzky, A. R.; Rees, C. W. Eds., Pergamon, Oxford, 1984; Vol. 6, pp. 575-577.
3. Thomas, E.W. In: Comprehensive Heterocyclic Chemistry I. Katritzky, A. R.; Rees, C. W. Eds., Pergamon, Oxford, 1984; Vol. 6, pp. 466-468.
4. Thomas, E.W. In: Comprehensive Heterocyclic Chemistry I. Katritzky, A. R.; Rees, C. W. Eds., Pergamon, Oxford, 1984; Vol. 6, pp. 509-511.
5. Abele, E.; Abele, R.; Lukevics, E. Oximes of five-membered heterocyclic compounds with three and four heteroatoms 2. Synthesis of derivatives, reactions, and biological activity. Chem. Heterocycl. Comp., 2008, 44, 769-792.
6. Behrouzi-Fardmoghadam, M.; Poorrajab, F.; Ardestani, S.K.; Emami, S.; Shafiee, A.; Foroumadi, A. Synthesis and in vitro antileishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2- yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines. Bioorg. Med. Chem., 2008, 16, 4509-4515.
7. Carvalho, S.A.; Lopes, F.A.S.; Salomäo, K.; Romeiro, N.C.; Wardell, S.M.S.V.; de Castro, S.L.; da Silva, E.F.; Fraga, C.A.M. Studies toward the structural optimization of new brazilizonerelated trypanocidal 1,3,4-thiadiazole-2-arylhydrazone derivatives. Bioorg. Med. Chem., 2008, 16, 413-421.
8. Poorrajab, F.; Ardestani, S.K.; Foroumadi, A.; Emami, S.; Kariminia, A.; Behrouzi-Fardmoghadam, M.; Shafiee, A. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species. Exp. Parasitol., 2009, 121, 323-330.
9. Mohammadhosseini, N.; Letafat, B.; Siavoshi, F.; Emami, S.; Safari, F.; Shafiee, A.; Foroumadi, A. Synthesis and in vitro anti- Helicobacter pylori activity of 2-[(chlorobenzyl)thio]-5-(5-nitro-2- furyl)-1,3,4-thiadiazoles. Med. Chem. Res., 2008, 17, 578-586.
10. Foroumadi, A.; Rineh, A.; Emami, S.; Siavoshi, F.; Massarrat, S.; Safari, F.; Rajabalian, S.; Falahati, M.; Lotfali, E.; Shafiee, A. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulphur containing alkyl side chain. Bioorg. Med. Chem. Lett., 2008, 18, 3315-3320.
11. Mirzaei, J.; Siavoshi, F.; Emami, S.; Safari, F.; Khoshayand, M.R.; Shafiee, A.; Foroumadi, A. Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2- yl]thiomorpholines and related compounds. Eur. J. Med. Chem., 2008, 43, 1575-1580.
12. Pintilie, O.; Profire, L.; Sunel, V.; Popa, M.; Pui, A. Synthesis and antimicrobial activity of some new 1,3,4thiadiazole and 1,2,4- triazole compounds having a D,L-methionine moiety. Molecules, 2007, 12, 103-113.
13. Gopalakrishnan, M.; Thanusu, J.; Kanagarajan, V. Synthesis and biological evaluation of 5,7-diaryl-4,4-dimethyl-4,5,6,7-tetrahydropyridino[ 3,4-d]-1,2,3-thiadiazoles. Med. Chem. Res., 2007, 16, 392-401.
14. Jazayeri, S.; Moshafi, M.H.; Firoozpour, L.; Emami, S.; Rajabalian, S.; Haddad, M.; Pahlavanzadeh, F.; Esnaashari, M.; Shafiee, A.; Foroumadi, A. Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids. Eur. J. Med. Chem., 2009, 44, 1205-1209.
15. Dabholkar, V.V.; Ansari, F.Y. Synthesis and biological studies of bis(thiadiazole/triazole) by sonication. Acta Pol. Pharm., 2008, 65, 521-526.
16. Padmavathi, V.; Nagendra Mohan, A.V.; Mahesh, K.; Padmaja, A. Aroylethenesulfonylacetic acid methyl ester-a synthon for novel sulfone linked bis heterocycles. Chem. Pharm. Bull., 2008, 56, 815-820.
17. Matysiak, J.; Malinski, Z. 2-(2,4-dihydroxyphenyl)-1,3,4- thiadiazole analogues: antifungal activity in vitro against Candida species. Russ. J. Bioorg. Chem., 2007, 33, 594-601.
18. Küçükgüzel, S.G.; Küçükgüzel, I.; Tatar, E.; Rollas, S.; Sxahin, F.; Gulluce, M.; De Clercq, E.; Kabasakal, L. Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. Eur. J. Med. Chem., 2007, 42, 893-901.
19. Mathew, V.; Keshavayya, J.; V.P. Vaidya, V.P. Giles, D. Studies on synthesis and pharmacological activities of 3,6-disubstituted- 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues. Eur. J. Med. Chem., 2007, 42, 823-840.
20. Kadi, A.A.; El-Brollosy, N.R.; Al-Deeb, O.A.; Habib, E.E.; Ibrahim, T.M.; El-Emam, A.A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted- 1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4- thiadiazoles. Eur. J. Med. Chem., 2007, 42, 235-242.
21. Kumar, H.; Javed, S.A.; Khan, S.A.; Amir, M. 1,3,4- Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: Synthesis and preliminary evaluation of biological properties. Eur. J. Med. Chem., 2008, 43, 2688-2698.
22. Amir, M.; Kumar, H.; Javed, S.A. Condensed bridgehead nitrogen heterocyclic system: Synthesis and pharmacological activities of 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives of ibuprofen and biphenyl-4-yloxy acetic acid. Eur. J. Med. Chem., 2008, 43, 2056-2066.
23. Amir, M.; Kumar, H.; Javed, S.A. Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives of naproxen. Bioorg. Med. Chem. Lett., 2007, 17, 4504-4508.
24. Amir, M.; Kumar, H.; Javed, S.A. Non-carboxylic analogues of naproxen: design, synthesis, and pharmacological evaluation of some 1,3,4-oxadiazole/thiadiazole and 1,2,4-triazole derivatives. Arch. Pharm. Chem. Life Sci., 2007, 340, 577-585.
25. Gadad, A.K.; Palkar, M.B.; Anand, K.; Noolvi, M.N.; Boreddy, T.S.; Wagwade, J. Synthesis and biological evaluation of 2- trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]- 1,3,4-thiadiazoles: A novel class of cyclooxygenase-2 inhibitors. Bioorg. Med. Chem., 2008, 16, 276-283.
26. Sharma, R.; Sainy, J.; Chandra Chaturvedi, S. 2-Amino-5-sulfanyl- 1,3,4-thiadiazoles: a new series of selective cyclooxygenase-2 inhibitors. Acta Pharm., 2008, 58, 317-326.
27. Trotsko, N.; Dobosz, M.; Jagiello-Wojtowicz, E. Cyclization of thiosemicarbazide derivatives of 5-arylidene-2,4-dioxothiazolidine-3-acetic acids to 1,3,4-thiadiazoles and their pharmacological properties. Acta Pol. Pharm. - Drug Res., 2007, 64, 227-231.
28. Zhan, P.; Liu, X.; Cao, Y.; Wanga, Y.; Pannecouque, C.; De Clercq, E. 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett., 2008, 18, 5368-5371.
29. Abdel-Hamid, M.K.; Abdel-Hafez, A.A.; El-Koussi, N.A.; Mahfouz, N.M.; Innocenti, A.; Supuran, C.T. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity. Bioorg. Med. Chem., 2007, 15, 6975-6984.
30. Wu, M.; Sun, Q.; Yang, C.; Chen, D.; Ding, J.; Chen, Y.; Lin, L.; Xie, Y. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents. Bioorg. Med. Chem. Lett., 2007, 17, 869-873.
31. Rzeski, W.; Matysiakb, J.; Kandefer-Szerszen, M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4- thiadiazole based compound. Bioorg. Med. Chem., 2007, 15, 3201-3207.
32. Wang, T.; Zhang, Y.H.; Yu, S.; Ji, H.; Lai, Y.S.; Peng, S. Synthesis and biological evaluation of novel thalidomide analogues as potential anticancer drugs. Chinese Chem. Lett., 2008, 19, 928-930.
33. Kong, X.; Zhang, Y.H.; Wang, T.; Lai, Y.S.; Peng, S. Synthesis and cytotoxic evaluation of novel dimethyl [1,1'-biphenyl]-2,2'- dicarboxylates bearing 1,3,4-thiadiazole moieties. Chem. Biodivers., 2008, 5, 1743-1752.
34. Tu, G.; Li, S.; Huang, H.; Li, G.; Xiong, F.; Mai, X.; Zhu, H.W.; Kuang, B.; Xu, W.F. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold. Bioorg. Med. Chem., 2008, 16, 6663-6668.
35. Tripathy, R.; Ghose, A.; Singh, J.; Bacon, E.R.; Angeles, T.S.; Yang, S.X.; Albom, M.S.; Aimone, L.D.; Herman, J.L.; Mallamo, J.P. 1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 1793-1798.
36. Matysiak, J. QSAR of antiproliferative activity of N-substituted 2- amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles in various human cancer cells. QSAR Comb. Sci., 2008, 27, 607-617.
37. Shen, L.; Zhang, Y.; Wang, A.; Sieber-McMaster, E.; Chen, X.; Pelton, P.; Xu, J.Z.; Yang, M.; Zhu, P.; Zhou, L.; Reuman, M.; Hu, Z.; Russell, R.; Gibbs, A.C.; Ross, H.; Demarest, K.; Murray, W.V.; Kuo, G.H. Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors α and δ. J. Med. Chem., 2007, 50, 3954-3963.
38. Shen, L.; Zhang, Y.; Wang, A.; Sieber-McMaster, E.; Chen, X.; Pelton, P.; Xu, J.Z.; Yang, M.; Zhu, P.; Zhou, L.; Reuman, M.; Hu, Z.; Russell, R.; Gibbs, A.C.; Ross, H.; Demarest, K.; Murray, W.V.; Kuo, G.H. Synthesis and structure-activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists. Bioorg. Med. Chem., 2008, 16, 3321-3341.
39. Castro, A.; Encinas, A.; Gil, C.; Bräse, S.; Porcal, W.; Pèrez, C.; Morenoc, F.J.; Martìneza, A. Non-ATP competitive glycogen synthase kinase 3β(GSK-3b) inhibitors: Study of structural requirements for thiadiazolidinone derivatives. Bioorg. Med. Chem., 2008, 16, 495-510.
40. Shashikant V. Bhandari, Bhavana J. Deshmane, Sudarshan C. Dangare, Suraj T. Gore, Vankekesh T. Raparti, Chetan V. Khachane, Aniket P. Sarkate. Anticovulsant activities of some novel 3-[5- substituted1, 3, 4-thiadiazole-yl]-2-styryl quinazoline-4(3h)-ones. Pharmacologyonline, 2008, 2, 604-613.
41. Yusuf, M.; Khan, R.A.; Ahmed, B. Syntheses and anti-depressant activity of 5-amino-1, 3, 4-thiadiazole-2-thiol imines and thiobenzyl derivatives. Bioorg. Med. Chem., 2008, 16, 8029-8034.
42. Siddiqui, N.; Shamsher Alam, M.; Ahsan, W. Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives. Acta Pharm. (Zagreb, Croatia), 2008, 58, 445-454.
43. Pattanayak, P.; Sharma, R.; Sahoo, P.K. Synthesis and evaluation of 2-amino-5-sulfanyl-1,3,4-thiadiazoles as antidepressant, anxiolytic, and anticonvulsant agents. Med. Chem. Res., 2009, 18, 351-361.
44. Mavrova, A. S; Wesselinova, D.; Tsenov, Y.A.; Denkova, P. Synthesis, cytotoxicity and effects of some 1,2,4-triazole and 1,3,4-thiadiazole derivatives on immunocompetent cells. Eur. J. Med. Chem., 2009, 44, 63-69.
45. Bulbul, M.; Kasimogullari, R.; Kufrevioglu, O.I. Amide derivatives with pyrazole carboxylic acids of 5-amino-1,3,4-thiadiazole-2- sulfonamide as new carbonic anhydrase inhibitors: synthesis and investigation of inhibitory effects. J. Enzyme Inhib. Med. Chem., 2008, 23(6) 895-900.
46. Teng, X.; Keys, H.; Jeevanandam, A.; Porco Jr., J.A.; Degterev, A.; Yuan, J.; Cuny, G.D. Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 6836-6840.
47. Teng, X.; Keys, H.; Yuan, J.; Degterev, A.; Cuny, G.D. Structure- activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors. Bioorg. Med. Chem. Lett., 2008, 18, 3219-3223.
48. Park, J.Y.; Ryu, I.A.; Park, J.H.; Ha, D.C.; Gong, Y.D. Parallel Synthesis of drug-like 5-amino-substituted 1,2,4-thiadiazole libraries using cyclization reactions of a carboxamidine dithiocarbamate linker. Synthesis, 2009, 6, 913-920.
49. Kim, J.Y.; Seo, H.J.; Lee, S.; Jung, M.E.; Ahn, K.; Kim, J.; Lee, J. Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists. Bioorg. Med. Chem. Lett., 2009, 19, 142-145.
50. Huber, V.J.; Tsujita, M.; Nakada, T. Identification of Aquaporin 4 inhibitors using in vitro and in silico methods. Bioorg. Med. Chem., 2009, 17, 411-417.
51. Smaine, F.; Pacchiano, F.; Rami, M.; Barragan-Montero, V.; Vullo, D.; Scozzafava, A.; Winuma, J.; Supuran, C.T. Carbonic anhydrase inhibitors: 2-Substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV. Bioorg. Med. Chem. Lett., 2008, 18, 6332-6335.